Implandata Ophthalmic Products GmbH (IOP) is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany.
IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.